A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4
Status:
Recruiting
Trial end date:
2022-11-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the delayed-type hypersensitivity (DTH) response
at the site of Candin intradermal injection in the presence of a targeted immune pathway
inhibitor.